UA100257C2 - Спосіб приготування екстрактів із ginkgo biloba - Google Patents
Спосіб приготування екстрактів із ginkgo biloba Download PDFInfo
- Publication number
- UA100257C2 UA100257C2 UAA201010750A UAA201010750A UA100257C2 UA 100257 C2 UA100257 C2 UA 100257C2 UA A201010750 A UAA201010750 A UA A201010750A UA A201010750 A UAA201010750 A UA A201010750A UA 100257 C2 UA100257 C2 UA 100257C2
- Authority
- UA
- Ukraine
- Prior art keywords
- solution
- adsorbent
- stage
- extract
- ethanol
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract description 35
- 239000000284 extract Substances 0.000 title abstract description 32
- 235000008100 Ginkgo biloba Nutrition 0.000 title abstract 3
- 244000194101 Ginkgo biloba Species 0.000 title abstract 3
- 239000002957 persistent organic pollutant Substances 0.000 abstract description 5
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 57
- 239000000243 solution Substances 0.000 description 49
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 39
- 239000003463 adsorbent Substances 0.000 description 39
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 36
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 34
- 239000000203 mixture Substances 0.000 description 27
- 239000007864 aqueous solution Substances 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- 239000007787 solid Substances 0.000 description 24
- 239000002904 solvent Substances 0.000 description 19
- 239000012074 organic phase Substances 0.000 description 16
- 150000001875 compounds Chemical class 0.000 description 13
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 11
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 11
- 235000011130 ammonium sulphate Nutrition 0.000 description 11
- 239000011324 bead Substances 0.000 description 8
- 229930195733 hydrocarbon Natural products 0.000 description 8
- 238000011002 quantification Methods 0.000 description 8
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 description 7
- 239000003344 environmental pollutant Substances 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 150000002430 hydrocarbons Chemical class 0.000 description 7
- 231100000719 pollutant Toxicity 0.000 description 7
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthene Chemical compound C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 229940046892 lead acetate Drugs 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 239000013557 residual solvent Substances 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 4
- 229930184727 ginkgolide Natural products 0.000 description 4
- 230000002085 persistent effect Effects 0.000 description 4
- 238000005191 phase separation Methods 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 4
- 229930002877 anthocyanin Natural products 0.000 description 3
- 235000010208 anthocyanin Nutrition 0.000 description 3
- 239000004410 anthocyanin Substances 0.000 description 3
- 150000004636 anthocyanins Chemical class 0.000 description 3
- 125000005605 benzo group Chemical group 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 102100037804 Inositol oxygenase Human genes 0.000 description 2
- 101150089916 Miox gene Proteins 0.000 description 2
- -1 RAN hydrocarbons Chemical class 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- WDECIBYCCFPHNR-UHFFFAOYSA-N chrysene Chemical compound C1=CC=CC2=CC=C3C4=CC=CC=C4C=CC3=C21 WDECIBYCCFPHNR-UHFFFAOYSA-N 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229910021514 lead(II) hydroxide Inorganic materials 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 239000000057 synthetic resin Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- GOHBXWHNJHENRX-UHFFFAOYSA-N 5-Methylchrysene Chemical compound C1=CC=CC2=C3C(C)=CC4=CC=CC=C4C3=CC=C21 GOHBXWHNJHENRX-UHFFFAOYSA-N 0.000 description 1
- TXVHTIQJNYSSKO-UHFFFAOYSA-N BeP Natural products C1=CC=C2C3=CC=CC=C3C3=CC=CC4=CC=C1C2=C34 TXVHTIQJNYSSKO-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 231100000770 Toxic Equivalency Factor Toxicity 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- RLJMLMKIBZAXJO-UHFFFAOYSA-N lead nitrate Chemical compound [O-][N+](=O)O[Pb]O[N+]([O-])=O RLJMLMKIBZAXJO-UHFFFAOYSA-N 0.000 description 1
- VLOJXAQYHIVPFI-UHFFFAOYSA-H lead(2+);diacetate;tetrahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[Pb+2].[Pb+2].[Pb+2].CC([O-])=O.CC([O-])=O VLOJXAQYHIVPFI-UHFFFAOYSA-H 0.000 description 1
- 150000002634 lipophilic molecules Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Hospice & Palliative Care (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Extraction Or Liquid Replacement (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0800625A FR2926994B1 (fr) | 2008-02-06 | 2008-02-06 | Nouveau procede pour la preparation d'extraits de ginkgo biloba |
| PCT/FR2009/000137 WO2009112709A2 (fr) | 2008-02-06 | 2009-02-06 | Nouveau procede pour la preparation d'extraits de ginkgo biloba |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA100257C2 true UA100257C2 (uk) | 2012-12-10 |
Family
ID=39731553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201010750A UA100257C2 (uk) | 2008-02-06 | 2009-06-02 | Спосіб приготування екстрактів із ginkgo biloba |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2249847B1 (enExample) |
| JP (1) | JP5710271B2 (enExample) |
| KR (1) | KR20100113619A (enExample) |
| CN (1) | CN101939016B (enExample) |
| EA (1) | EA022346B1 (enExample) |
| ES (1) | ES2632507T3 (enExample) |
| FR (1) | FR2926994B1 (enExample) |
| UA (1) | UA100257C2 (enExample) |
| WO (1) | WO2009112709A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20090548A1 (it) * | 2009-04-06 | 2010-10-07 | Indena Spa | Processo di rimozione di pesticidi da estratti di ginkgo biloba e estratti ottenibili da detto processo |
| KR101898709B1 (ko) * | 2016-09-27 | 2018-09-13 | 주식회사 한성바이오파마 | 수용성 은행잎 추출액 및 추출분말의 제조방법 |
| DE102023131617A1 (de) | 2023-11-14 | 2025-05-15 | Dr. Willmar Schwabe Gmbh & Co. Kg | Verfahren zur Herstellung von Ginkgoextrakten mit hohem Gehalt an Proanthocyanidinen und Nahrungsergänzungsmittel und Arzneimittel enthaltend Ginkgoextrakte |
| FR3156652A1 (fr) * | 2023-12-18 | 2025-06-20 | Beng Poon Teng | Procédé de préparation d’un extrait de feuilles de ginkgo biloba hautement enrichi en proanthocyanidins depourvu de flavonoïdes et de trilactones terpéniques |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR940002796B1 (ko) * | 1989-06-16 | 1994-04-02 | 주식회사 선경인더스트리 | 은행잎에서 징코라이드를 분리 및 정제하는 방법 |
| DE3940091A1 (de) | 1989-12-04 | 1991-06-06 | Schwabe Willmar Gmbh & Co | Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel |
| DE19756848C2 (de) | 1997-12-19 | 2003-01-16 | Schwabe Willmar Gmbh & Co | Extrakte aus Blättern von Ginkgo biloba mit vermindertem Gehalt an 4'-O-Methylpyridoxin und Biflavonen |
| FR2823116B1 (fr) * | 2001-04-10 | 2004-11-19 | Sod Conseils Rech Applic | Procede de preparation d'une extrait de feuilles de ginkgo biloba hautement enrichi en principes actifs |
| US20060006765A1 (en) * | 2004-07-09 | 2006-01-12 | Jongtae Yuk | Apparatus and method to transmit and receive acoustic wave energy |
| WO2006117168A2 (de) * | 2005-05-03 | 2006-11-09 | Dr. Willmar Schwabe Gmbh & Co. Kg | Verfahren zur herstellung von ginkgoextrakten mit vermindertem gehalt an unpolaren pflanzeninhaltsstoffen und umweltbedingten unpolaren fremdstoffen |
| EP1868626B1 (en) * | 2005-05-03 | 2008-09-10 | Dr. Willmar Schwabe GmbH & Co. KG | Improved method for preparing ginkgo extracts having a reduced content of polycyclic aromatic hydrocarbons |
| CN1891242B (zh) * | 2005-07-06 | 2012-01-04 | 徐州技源天然保健品有限公司 | 一种从银杏叶提取物中脱除多环芳烃的生产工艺 |
-
2008
- 2008-02-06 FR FR0800625A patent/FR2926994B1/fr active Active
-
2009
- 2009-02-06 WO PCT/FR2009/000137 patent/WO2009112709A2/fr not_active Ceased
- 2009-02-06 ES ES09720028.1T patent/ES2632507T3/es active Active
- 2009-02-06 JP JP2010545526A patent/JP5710271B2/ja active Active
- 2009-02-06 CN CN2009801044220A patent/CN101939016B/zh active Active
- 2009-02-06 EA EA201070924A patent/EA022346B1/ru not_active IP Right Cessation
- 2009-02-06 EP EP09720028.1A patent/EP2249847B1/fr not_active Revoked
- 2009-02-06 KR KR1020107019665A patent/KR20100113619A/ko not_active Ceased
- 2009-06-02 UA UAA201010750A patent/UA100257C2/uk unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5710271B2 (ja) | 2015-04-30 |
| JP2011511047A (ja) | 2011-04-07 |
| EP2249847A2 (fr) | 2010-11-17 |
| FR2926994B1 (fr) | 2010-08-27 |
| CN101939016A (zh) | 2011-01-05 |
| EA022346B1 (ru) | 2015-12-30 |
| KR20100113619A (ko) | 2010-10-21 |
| FR2926994A1 (fr) | 2009-08-07 |
| ES2632507T3 (es) | 2017-09-13 |
| WO2009112709A2 (fr) | 2009-09-17 |
| CN101939016B (zh) | 2013-09-18 |
| EA201070924A1 (ru) | 2010-12-30 |
| WO2009112709A3 (fr) | 2010-05-06 |
| EP2249847B1 (fr) | 2017-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2688410C (en) | A composition comprising camomile and black cumin oil and therapeutic uses thereof | |
| Santoyo et al. | Supercritical fluid extraction as an alternative process to obtain antiviral agents from thyme species | |
| Qabaha et al. | Anti-inflammatory activity of Eucalyptus spp. and Pistascia lentiscus leaf extracts | |
| JP5710271B2 (ja) | イチョウのエキスを製造する新規な方法 | |
| TWI610676B (zh) | 神經細胞死抑制劑、抗阿茲海默症劑、抗腦機能減退劑、具有抗阿茲海默症作用或抗腦機能減退作用的醫藥品及神經細胞死抑制劑的製造方法 | |
| ITMI941112A1 (it) | Alcaloidi da mappia foetida, loro uso e formulazioni che li contengono | |
| JP6497791B2 (ja) | ミクログリアｉｌ−６産生抑制剤、中枢神経系抗炎症剤、抗神経変性疾患剤、抗精神神経疾患剤、医薬品及び食品 | |
| KR20200074189A (ko) | 비사쿠론 추출 방법 | |
| WO2006117168A2 (de) | Verfahren zur herstellung von ginkgoextrakten mit vermindertem gehalt an unpolaren pflanzeninhaltsstoffen und umweltbedingten unpolaren fremdstoffen | |
| JP2016517863A (ja) | ユリノキの樹皮から慢性骨髄性白血病の治療成分を抽出分離する方法 | |
| EP3335578A1 (en) | Red rice extracts standardised in total monacolins and industrial processes for the production thereof | |
| JP6312767B2 (ja) | ビサクロン抽出方法 | |
| JP3623247B2 (ja) | 茶葉サポニン類を含む薬剤 | |
| EP1868626A1 (en) | Improved method for preparing ginkgo extracts having a reduced content of polycyclic aromatic hydrocarbons | |
| CN100425253C (zh) | 一种地乌总皂苷的制备方法 | |
| CN116115679B (zh) | 一种三叉苦提取物在制备治疗脓毒症相关性脑病药物中的应用 | |
| JP5441433B2 (ja) | カムカムフルーツ果汁含有肝機能改善剤 | |
| HK1150539A (en) | Novel method for preparing extracts of ginkgo biloba | |
| JP6473526B2 (ja) | ビサクロン抽出方法 | |
| BR112016009457B1 (pt) | Processo para purificação de lecitina | |
| Oyenike Animashaun et al. | Gas chromatography-mass spectrometry analysis, phytochemical screening, antioxidant and antibacterial activity of methanol root extract of rhaphiostylis beninensis (Hook. f.) Planch.[family ICACINACEAE] against Uropathogens | |
| Gnanaiah et al. | ISOLATION, PURIFICATION & CHARACTERIZATION OF ACTIVE COMPOUND FROM ANDROGRAPHIS PANICULATA. L AND TESTING ITS ANTI-VENOM AND CYTOTOXIC ACTIVITY BY IN-VITRO & IN-VIVO STUDIES | |
| WO2022084908A1 (en) | Compositions for inhibiting sars-cov-2 virus | |
| HK1150539B (en) | Novel method for preparing extracts of ginkgo biloba | |
| Jung et al. | Inhibition effects of isolated compounds from Artemisia rubripes Nakai of the classical pathway on the complement system. |